Major health authorities around the world are implementing or preparing to implement the next major version of eCTD for regulatory submissions. As the most consequential update to eCTD in the last two decades, it is essential for pharmaceutical and biotech companies to stay well-informed and poised to make this transition.
In this webinar, we will provide a comprehensive overview of when and how each region is adopting eCTD 4.0, including the latest updates from major regulatory…
